Medtronic: Insertable Cardiac Monitor Leads to Effective Diagnosis

Medtronic, Inc. Friday announced the publication of data showing that use of its Reveal family of Insertable Cardiac Monitors led to diagnosis and specific treatment for 78 percent (170 of 218) of patients who experienced a recurrent syncopal (fainting) event during the course of the study.
CNBC